Endocyte, Inc. (delisted) News - ECYT

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
LEVEL 1 STARTER
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Endocyte, Inc. (delisted) ECYT NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.00 0.00% 23.99 0.00 0.00 0.00 23.99 20:00:00
more quote information »

Recent News

Date Time Source Heading
2/14/201917:25EDGARAmended Statement of Ownership (sc 13g/a)
12/31/201810:37EDGARTermination of Registration of a Class of Security Under..
12/27/201806:02EDGARNotice of Effectiveness (effect)
12/21/201812:57EDGARStatement of Changes in Beneficial Ownership (4)
12/21/201812:56EDGARStatement of Changes in Beneficial Ownership (4)
12/21/201812:55EDGARStatement of Changes in Beneficial Ownership (4)
12/21/201812:55EDGARStatement of Changes in Beneficial Ownership (4)
12/21/201812:55EDGARStatement of Changes in Beneficial Ownership (4)
12/21/201812:54EDGARStatement of Changes in Beneficial Ownership (4)
12/21/201812:54EDGARStatement of Changes in Beneficial Ownership (4)
12/21/201812:53EDGARStatement of Changes in Beneficial Ownership (4)
12/21/201812:51EDGARStatement of Changes in Beneficial Ownership (4)
12/21/201812:50EDGARStatement of Changes in Beneficial Ownership (4)
12/21/201812:50EDGARStatement of Changes in Beneficial Ownership (4)
12/21/201812:49EDGARStatement of Changes in Beneficial Ownership (4)
12/21/201812:48EDGARStatement of Changes in Beneficial Ownership (4)
12/21/201811:56EDGARPost-effective Amendment to an S-8 Filing (s-8 Pos)
12/21/201811:55EDGARPost-effective Amendment to an S-8 Filing (s-8 Pos)
12/21/201811:55EDGARPost-effective Amendment to an S-8 Filing (s-8 Pos)
12/21/201811:55EDGARPost-effective Amendment to an S-8 Filing (s-8 Pos)
12/21/201811:54EDGARPost-effective Amendment to an S-8 Filing (s-8 Pos)
12/21/201811:53EDGARPost-effective Amendment to an S-8 Filing (s-8 Pos)
12/21/201811:51EDGARPost-effective Amendment to an Automatic Shelf Registration..
12/21/201811:47EDGARCurrent Report Filing (8-k)
12/21/201808:47EDGARNotification Filed by National Security Exchange to Report..
12/20/201809:44EDGARPost-effective Amendment to Registration Statement (pos Am)
12/20/201809:25GLOBEEndocyte Stockholders Approve Merger Agreement with Novartis..
12/19/201816:32EDGARStatement of Changes in Beneficial Ownership (4)
12/19/201816:16EDGARStatement of Changes in Beneficial Ownership (4)
12/19/201816:16EDGARStatement of Changes in Beneficial Ownership (4)
12/19/201816:15EDGARStatement of Changes in Beneficial Ownership (4)
12/19/201816:15EDGARStatement of Changes in Beneficial Ownership (4)
12/17/201806:56EDGARCurrent Report Filing (8-k)
12/12/201816:17EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
12/03/201807:57EDGARCurrent Report Filing (8-k)
11/16/201806:20EDGARProxy Statement - Merger or Acquistion (definitive)..
11/15/201816:19EDGARInitial Statement of Beneficial Ownership (3)
11/08/201816:43EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
11/08/201812:25EDGARQuarterly Report (10-q)
11/07/201817:32EDGARCurrent Report Filing (8-k)
11/07/201816:01GLOBEEndocyte Provides Third Quarter 2018 Financial Results and..
11/06/201817:37EDGARAdditional Proxy Soliciting Materials - Non-management..
11/05/201816:51EDGARAdditional Proxy Soliciting Materials - Non-management..
11/01/201810:33EDGARStatement of Beneficial Ownership (sc 13d)
10/31/201817:31EDGARProxy Statement - Merger or Acquistion (preliminary)..
10/19/201816:19EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
10/19/201803:02DJNNovartis Deal Reflects Stress on High-Value Drugs -- WSJ
10/18/201817:19EDGARAdditional Proxy Soliciting Materials - Non-management..
10/18/201817:03EDGARAdditional Proxy Soliciting Materials - Non-management..
10/18/201817:03EDGARAdditional Proxy Soliciting Materials - Non-management..
See more news about this stock »
Your Recent History
NASDAQ
ECYT
Endocyte, ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190618 13:21:21